Irl Greenwell to Treatment Outcome
This is a "connection" page, showing publications Irl Greenwell has written about Treatment Outcome.
Connection Strength
0.022
-
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study. J Hematol Oncol. 2022 07 16; 15(1):96.
Score: 0.022